![](https://www.arthurcox.com/wp-content/uploads/2019/12/Colin_Kavanagh-768x576.jpg)
Colin Kavanagh
+353 1 920 1196
[email protected]
Ten Earlsfort Terrace
Dublin 2
D02 T380
Ireland
Colin is a partner in the Corporate and M&A Group. He is head of the firm’s Life Sciences Group.
Colin provides corporate, commercial, regulatory and intellectual property advice across a range of industries but in particular the life sciences industry. Colin also advises clients in other intellectual property-based industries, including in the food, beverage, agri-business, media, telecoms, sports, entertainment and technology sectors. Colin advises on mergers, acquisitions and investments, cross-border tax and intellectual property re-organisations, post-acquisition integrations and corporate treasury activities. Colin advises on the drafting and negotiation of commercial contracts and arrangements across a range of sectors, with a particular focus on IP based industries. Colin also advises on the regulation of the life sciences and media industries in Ireland.
In The Legal 500: Europe, Middle East and Africa, 2024, Colin was ranked:
- Hall of Fame: Media & Entertainment
- Leading Individual: Healthcare & Life Sciences
Relevant Experience
- Advising a Danish co-operative on the acquisition of a controlling interest in a Danish health and nutrition ingredients business.
- Advising a US pharmaceutical company on the disposal of a manufacturing plant to a Korean CMO
- Advising Spanish multinational on the acquisition of a Communications infrastructure business in Ireland
- Advising a Canadian business process outsourcing provider on an investment in an Irish business
- Advising the shareholders of an Irish medical device business on a sale to a US multinational
- Advising a US biotech company on the acquisition of an Irish biotech business
- Advising a range of business on supply, sourcing, outsourcing and contract manufacturing arrangements
- Advising pharmaceutical, medtech and biotech businesses on product clinical trials, reimbursement, promotional and transactional regulatory issues
- Advising an Irish telecoms provider on the establishment of a broadcasting platform and the acquisition of a sports broadcaster
- Advising a global media company on the acquisition of an Irish television station
- Advising on the disposal of a number of radio broadcasters to a global media company
Related Content
![](https://www.arthurcox.com/wp-content/uploads/2023/02/LR-Purple-19-kaleidoscope-709x576.jpg)
Regulatory Investigations – A Guide to Dawn Raids
![](https://www.arthurcox.com/wp-content/uploads/2024/05/Featured-image-.jpg)
HSE and IPHA announce model Clinical Trial Agreement for tripartite clinical trials
![](https://www.arthurcox.com/wp-content/uploads/2019/12/LM_ACDR_0051-768x576.jpg)
Arthur Cox advises Chanelle Pharma on sale to Exponent
![](https://www.arthurcox.com/wp-content/uploads/2021/11/LR-Building-exterior-3-768x576.jpg)
Intellectual Property team recognised in IP STARS 2023
![](https://www.arthurcox.com/wp-content/uploads/2023/06/Copy-of-Copy-of-Self-Post-Canva-template-768x576.png)
Arthur Cox contributes to IBA’s Comparative Legal Guide on Telemedicine
![](https://www.arthurcox.com/wp-content/uploads/2023/01/Briefing-Life-Sciences-1-768x576.png)
2023 Priority Legislation for Publication in the Life Sciences Sector
![Outside towards Arthur Cox building. 6th floor of building](https://www.arthurcox.com/wp-content/uploads/2021/11/LR-Balcony7-768x576.jpg)
Cambrex Corporation acquisition of Q1 Scientific Limited
![](https://www.arthurcox.com/wp-content/uploads/2021/11/LR-Reception1-768x576.jpg)
Biosynth Carbosynth acquisition of Aalto Bio Reagents
![](https://www.arthurcox.com/wp-content/uploads/2021/01/Briefing-43-scaled-768x576.jpg)
PRA Health Sciences proposed acquisition by ICON plc
![](https://www.arthurcox.com/wp-content/uploads/2019/12/LM_ACDR_2381-768x576.jpg)
Arthur Cox named European Corporate Team of the Year
![](https://www.arthurcox.com/wp-content/uploads/2019/12/LM_ACDR_1981-768x576.jpg)
Arthur Cox Leads Mergermarket League Table
![](https://www.arthurcox.com/wp-content/uploads/2019/12/img1-768x576.jpg)
Arthur Cox tops Mergermarket M&A Legal Adviser league tables
![](https://www.arthurcox.com/wp-content/uploads/2019/12/LM_ACDR_1826-768x576.jpg)
Arthur Cox Tops Mergermarket M&A Legal Adviser League Tables
![](https://www.arthurcox.com/wp-content/uploads/2019/12/Arthur-Cox-Named-MA-Legal-Adviser-of-the-Year-for-Ireland-768x576.jpg)
Arthur Cox Named M&A Legal Adviser of the Year for Ireland
![](https://www.arthurcox.com/wp-content/uploads/2023/01/Copy-of-Copy-of-Copy-of-Self-Post-Canva-template--768x576.jpg)
2023 Priority Legislation for Publication in the Healthcare Sector
![](https://www.arthurcox.com/wp-content/uploads/2021/11/LR-Entrance1-768x576.jpg)
Arthur Cox contributes to ICLG Pharmaceutical Advertising 2022
![](https://www.arthurcox.com/wp-content/uploads/2021/11/LR-Stephens-Green2-768x576.jpg)
In Vitro Diagnostic Medical Devices Regulation enters into full effect
![](https://www.arthurcox.com/wp-content/uploads/2021/11/LR-Sixth-Floor2-768x576.jpg)
International Comparative Legal Guide: Digital Health 2022
![](https://www.arthurcox.com/wp-content/uploads/2022/01/Clinical-Trials-Image-01-768x1024-1-768x576.jpeg)
The Clinical Trial Regulation: Get Ready for Go-Live – Part 3
![](https://www.arthurcox.com/wp-content/uploads/2021/11/LR-Atrium4-768x576.jpg)
IPHA publishes new Framework Agreement on the Supply and Pricing of Medicines
![](https://www.arthurcox.com/wp-content/uploads/2022/01/Clinical-Trials-Image-01-768x1024-1-768x576.jpeg)
The Clinical Trial Regulation: Get Ready for Go-Live – Part 2
![](https://www.arthurcox.com/wp-content/uploads/2022/01/Clinical-Trials-Image-01-768x1024-1-768x576.jpeg)
The Clinical Trial Regulation: Get Ready for Go-Live – Part 1
![](https://www.arthurcox.com/wp-content/uploads/2021/11/LR-Stairs5-768x576.jpg)
IPHA model Clinical Trial Agreement
![](https://www.arthurcox.com/wp-content/uploads/2019/12/LM_ACDR_2381-768x576.jpg)
Arthur Cox contributes to ICLG Pharmaceutical Advertising 2021
![](https://www.arthurcox.com/wp-content/uploads/2021/01/Briefing-42-768x576.jpg)
What you need to know about the new Regulation on transparency of risk assessment in the food chain
![](https://www.arthurcox.com/wp-content/uploads/2019/12/LM_ACDR_2952-768x576.jpg)
HPRA establish Compliance Programme on Advisory Boards
![](https://www.arthurcox.com/wp-content/uploads/2021/02/iStock-157418405-1920x1280LR-768x576.jpg)
2021 priority legislation for publication in the Healthcare and Life Sciences sectors
![](https://www.arthurcox.com/wp-content/uploads/2021/01/Briefing-41-768x576.jpg)
Arthur Cox contributes to Practical Law’s Life Sciences Global Guide 2021
![](https://www.arthurcox.com/wp-content/uploads/2019/12/LM_ACDR_2555-768x576.jpg)
Updates to the Irish Pharmaceutical Healthcare Association (“IPHA”) Codes
![](https://www.arthurcox.com/wp-content/uploads/2019/12/LM_ACDR_1981-768x576.jpg)
Impact of EU/UK Trade and Cooperation Agreement on Life Sciences Sector
![](https://www.arthurcox.com/wp-content/uploads/2019/12/LM_ACDR_0023-768x576.jpg)
New Medical Device Regulations – Are You Ready?
![](https://www.arthurcox.com/wp-content/uploads/2019/12/LM_ACDR_2397-768x576.jpg)